LitAlert ~~ GeneLit.com

    • Lynparza Cost-Effectiveness Analysis IDs Pancreatic Cancer Subgroups That Derive Most Benefit.
    • Kanski A.
    • Precision Oncology News. 2020 Dec 17.
    • Research news
    • Novel Therapies for Triple-Negative Breast Cancer.
    • Nanda R.
    • Clin Adv Hematol Oncol. 2020 Dec;18(12).
    • PARP Inhibitors in Prostate Cancer: Practical Guidance for Busy Clinicians.
    • VanderWeele DJ, Hussain M.
    • Clin Adv Hematol Oncol. 2020 Dec;18(12).